OTC: NURPF - Neuren Pharmaceuticals Limited

六个月盈利: -21.88%
股息率: 0.00%
部门: Healthcare

促销时间表 Neuren Pharmaceuticals Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as has completed Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase I clinical trial for the treatment of Phelan-McDermid, Angelman, Pitt Hopkins, and Prader-Will syndromes. In addition, it provides development services; and holds loan funded shares.

更多详情
Neuren Pharmaceuticals Limited was incorporated in 2001 and is based in Camberwell, Australia.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета aud
Сайт https://www.neurenpharma.com
Цена ао 7.25
每日价格变化: 0% (7.25)
每周价格变化: -6.58% (7.7607)
每月价格变化: -13.28% (8.36)
3个月内价格变化: -9.38% (8)
六个月内的价格变化: -21.88% (9.28)
每年价格变化: -48.21% (14)
3年内价格变化: +137.35% (3.0545)
5年内价格变化: +279.58% (1.91)
10年价格变化: 0% (7.25)
年初以来价格变化: -7.85% (7.868)
所有参数

低估

姓名 意义 年级
P/S 12.7 1
P/BV 14.35 1
P/E 18.75 7
EV/EBITDA 14.7 7
全部的: 5.63

效率

姓名 意义 年级
ROA, % 63.35 10
ROE, % 76.55 10
全部的: 8.33

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA 0 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 46756.97 10
盈利能力 Ebitda, % -1821.79 0
盈利能力 EPS, % -2025.02 0
全部的: 2
更多详情

机构 体积 分享, %
Vanguard International Stock Index-Total Intl Stock Indx 1480133 1.16
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 877162 0.69
iShares Core MSCI EAFE ETF 652944 0.51
iShares MSCI EAFE Small Cap ETF 436465 0.34
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 403572 0.32
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 215442 0.17
iShares Core MSCI Total International Stock ETF 140892 0.11
Vanguard International Stock Index-Pacific Stock Index 128668 0.1
College Retirement Equities Fund-Stock Account 85378 0.07
SEI Institutional International Tr-International Equity 71485 0.06



导师 职称 支付 出生年份
Mr. Jonathan Charles Pilcher A.C.A., ACA, B.Sc., BSc (Hons), F.C.A. CEO, MD & Executive Director 714.28k
Ms. Lauren Frazer C.A. CFO & Company Secretary N/A
Mr. Lawrence Glass BA (Biology) Chief Science Officer N/A
Mr. Gerry Zhao Vice President of Corporate Development N/A
Dr. Liza A. Squires M.D. Chief Medical Officer N/A

地址: Australia, Camberwell, 697 Burke Road - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.neurenpharma.com